GlobeNewsWire
21 Jul 2026, 20:46 UTC · 2h ago
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
GlobeNewsWire
21 Jul 2026, 20:46 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Dyne Therapeutics has commenced an underwritten public offering of $300 million of common stock. — Public offerings typically result in immediate share dilution for existing stockholders, often leading to a short-term decline in stock price.
-0.60Dyne intends to grant underwriters a 30-day option to purchase up to an additional $45 million of shares. — The potential for additional shares to enter the market increases the total possible dilution beyond the primary $300 million offering.
-0.30Which stocks this story touches
The company is announcing a public offering of common stock, which typically leads to share dilution for existing investors.
Continue reading
6 related stories
Top 1 mover · tap to explore
[a_to_b] Morgan Stanley is acting as a joint book-running manager for Dyne Therapeutics' public offering.
[a_to_b] Jefferies is acting as a joint book-running manager for Dyne Therapeutics' public offering.
[a_to_b] Evercore is acting as a joint book-running manager for Dyne Therapeutics' public offering.
[a_to_b] Raymond James is acting as a joint book-running manager for Dyne Therapeutics' public offering.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
49m ago
